By Gerard Naval

THE Food and Drug Administration (FDA) yesterday warned the public against consuming three unregistered drug products – “OTC Lixiao Zhuangyaojianshen Wan,” “Diclofenac Sodium Sustained Release Capsules 0.1g,” and “OTC Yulin® Shiduqing Jiaonang.”

It said the three products have not gone through the FDA registration process and have not been issued a “proper authorization in the form of a certificate of product registration.”